Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Plants (Basel) ; 12(10)2023 May 12.
Artículo en Inglés | MEDLINE | ID: mdl-37653885

RESUMEN

The Tanacetum vulgare L. (Tansy) has several ethnobotanical uses, mostly related to the essential oil and sesquiterpene lactones, whereas information regarding other compounds is scarce. This research is designed to characterize the phenolic compounds (flavonoids, phenolic acids, and tannins) to analyze the thujone (which is toxic in high concentrations) content and to detect the antioxidant activity (DPPH assay) of extracts. The main highlights of our work provide a chemical profile of phenolic compounds of T. vulgare harvested from different regions of Latvia, as well as simultaneously support the ethnomedicinal uses for wild T. vulgare through the integration of phenolic compounds as one of the value constituents of leaves and flowers. The extraction yield was 18 to 20% for leaves and 8 to 16% for flowers. The total phenol content in the extracts of T. vulgare as well as their antioxidant activity was different between collection regions and the aerial parts ranging from 134 to 218 mg GAE/g and 32 to 182 mg L-1, respectively. A remarkable variation in the thujone (α + ß) content (0.4% up to 6%) was detected in the extracts. T. vulgare leaf extracts were rich in tannins (up to 19%). According to the parameters detected, the extracts of T. vulgare could be considered promising for the development of new herbal products.

2.
Ideggyogy Sz ; 62(7-8): 220-9, 2009 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-19685700

RESUMEN

Pantethine, the stable disulfide form of pantetheine, is the major precursor of coenzyme A, which plays a central role in the metabolism of lipids and carbohydrates. Coenzyme A is a cofactor in over 70 enzymatic pathways, including fatty acid oxidation, carbohydrate metabolism, pyruvate degradation, amino acid catabolism, haem synthesis, acetylcholine synthesis, phase II detoxification, acetylation, etc. Pantethine has beneficial effects in vascular disease, it able to decrease the hyperlipidaemia, moderate the platelet function and prevent the lipid-peroxidation. Moreover its neuro-endocrinological regulating role, its good influence on cataract and cystinosis are also proved. This molecule is a well-tolerated therapeutic agent; the frequency of its side-effect is very low and mild. Based on these preclinical and clinical data, it could be recommended using this compound as adjuvant therapy.


Asunto(s)
Antioxidantes/farmacología , Coenzima A/biosíntesis , Ácidos Grasos/metabolismo , Hipolipemiantes/farmacología , Peroxidación de Lípido/efectos de los fármacos , Panteteína/análogos & derivados , Acetilcolina/biosíntesis , Animales , Antioxidantes/química , Antioxidantes/uso terapéutico , Aterosclerosis/metabolismo , Aterosclerosis/prevención & control , Plaquetas/efectos de los fármacos , Catarata/inducido químicamente , Catarata/prevención & control , Sistema Nervioso Central/efectos de los fármacos , Coenzima A/metabolismo , Cistina/efectos de los fármacos , Cistinosis/prevención & control , Carbohidratos de la Dieta/metabolismo , Humanos , Hiperlipidemias/tratamiento farmacológico , Hiperlipidemias/metabolismo , Hipolipemiantes/uso terapéutico , Oxidación-Reducción , Panteteína/química , Panteteína/metabolismo , Panteteína/farmacología , Panteteína/uso terapéutico , Ácido Pantoténico/farmacología , Piruvatos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA